Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Several mechanisms have been proposed to explain the activity of Immunomodulatory Drugs (IMiDs) in Multiple Myeloma (MM). These included demonstrable anti-angiogenic, antiproliferative and immune modulation effects. The precise cellular targets and molecular mechanisms have only recently become clear.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi